Marc-Antoine Lauzon

577 citations
32 papers · 424 indexed · h-index 12

Marc-Antoine Lauzon

30 papers receiving 421 citations

Peers

Marc-Antoine Lauzon
Comparison fields: 5 of 76
  • Biomaterials 128
  • Molecular Medicine 35
  • Pharmaceutical Science 39
  • Biomedical Engineering 153
  • Genetics 34
Replace Lingchi Kong with:
Lingchi Kong China
Morteza Heidarzadeh Iran
Nihui Zhang China
Chengcheng Du China
Xiaozhong Zhou China
Carlisle R. DeJulius United States
Aidong Deng China
Xiang Cui China
Jafar Ai Iran
Ranyang Tao United States
Marc-Antoine Lauzon relative to Lingchi Kong China Lingchi Kong's profile →
Citations per field
00.5×3.3×
Lingchi Kong · 1×
Citations per year

Countries citing papers authored by Marc-Antoine Lauzon

Since Specialization
Citations

This map shows the geographic impact of Marc-Antoine Lauzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc-Antoine Lauzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc-Antoine Lauzon more than expected).

Fields of papers citing papers by Marc-Antoine Lauzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc-Antoine Lauzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc-Antoine Lauzon. The network helps show where Marc-Antoine Lauzon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marc-Antoine Lauzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc-Antoine Lauzon Line = papers co-authored together Marc-Antoine Lauzon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20246
4 20243
5 20244
6 20240
7 20242
8 20235
9 20236
10 20223
11 202123
12 20207
13 20189
14 20188
15 201627
16 201545
17 201521
18 201411
19 201411
20 201248

About Marc-Antoine Lauzon

Marc-Antoine Lauzon is a scholar working on Biomaterials, Molecular Medicine and Pharmaceutical Science, having authored 32 papers that have together received 424 indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (6 papers), Nanoparticle-Based Drug Delivery (6 papers), 3D Printing in Biomedical Research (5 papers), Bone and Dental Protein Studies (4 papers), Hydrogels: synthesis, properties, applications (4 papers), Advanced Drug Delivery Systems (4 papers), Alzheimer's disease research and treatments (3 papers) and TGF-β signaling in diseases (3 papers). The work is most often cited by research in Biomaterials (128 citations), Molecular Medicine (35 citations) and Pharmaceutical Science (39 citations). Marc-Antoine Lauzon has collaborated with scholars based in Canada and France. Frequent co-authors include Nathalie Faucheux, Bernard Marcos, Alex Daviau, Olivier Drevelle, Éric Bergeron, Nick Virgilio, Guillaume Grenier, Benoît Paquette, Hélène Therriault and Frédéric Balg. Their work appears in journals such as Journal of Controlled Release, Materials Science and Engineering C, Pharmaceutics, Carbohydrate Polymers and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026